based on in vitro activity , difloxacin and a-56620 merit in vivo assessment for management of both c. trachomatis and n. gonorrhoeae infections , and cefixime shows considerable promise for treatment of n. gonorrhoeae infections .
C0060400
cefixime
C0018081
gonorrhoeae